# Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

> **NCT00367822** · PHASE3 · COMPLETED · sponsor: **Axxonis Pharma AG** · enrollment: 300 (—)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Lisuride
- **DRUG:** Ropinirole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00367822
- **Lead sponsor:** Axxonis Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2012-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367822, "Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00367822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*